Search

Your search keyword '"Aubert, Dominique"' showing total 447 results

Search Constraints

Start Over You searched for: Author "Aubert, Dominique" Remove constraint Author: "Aubert, Dominique"
447 results on '"Aubert, Dominique"'

Search Results

401. The rural-urban effect on spatial genetic structure of type II Toxoplasma gondii strains involved in human congenital toxoplasmosis, France, 2002-2009.

402. Spatial distribution of Toxoplasma gondii oocysts in soil in a rural area: Influence of cats and land use.

403. Toxoplasmosis in natural populations of ungulates in France: prevalence and spatiotemporal variations.

404. Species or local environment, what determines the infection of rodents by Toxoplasma gondii?

405. Bages-Sigean and Canet-St Nazaire lagoons (France): physico-chemical characteristics and contaminant concentrations (Cu, Cd, PCBs and PBDEs) as environmental quality of water and sediment.

406. Environmental determinants of spatial and temporal variations in the transmission of Toxoplasma gondii in its definitive hosts.

407. Implicit sequence learning in a continuous pursuit-tracking task.

408. Tools and methods for detecting and characterizing giardia, cryptosporidium, and toxoplasma parasites in marine mollusks.

409. Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE).

410. Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters.

411. Environmental factors associated with the seroprevalence of Toxoplasma gondii in Wild Boars (Sus scrofa), France.

412. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil.

413. New strategy for the survey of Toxoplasma gondii in meat for human consumption.

414. Interaction forces drive the environmental transmission of pathogenic protozoa.

415. Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient.

416. Specific micro RNA-regulated TetR-KRAB transcriptional control of transgene expression in viral vector-transduced cells.

417. Development of a sensitive method for Toxoplasma gondii oocyst extraction in soil.

418. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France.

419. The role of ATP-binding cassette (ABC) proteins in protozoan parasites.

420. Direct in vivo cell lineage analysis in the retrorsine and 2AAF models of liver injury after genetic labeling in adult and newborn rats.

421. Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors.

422. Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping.

423. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings.

424. A new surgical approach to improve gene transfer in liver using lentiviral vectors.

425. Molecular characterization and expression analysis of a P-glycoprotein homologue in Toxoplasma gondii.

426. Spatial distribution of soil contamination by Toxoplasma gondii in relation to cat defecation behaviour in an urban area.

427. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.

428. Prevalence of Toxoplasma gondii in raptors from France.

429. Prevalence of Toxoplasma gondii in small mammals from the Ardennes region, France.

430. A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studies.

431. Reduced secretion and expression of gelatinase profile in Toxoplasma gondii-infected human monocytic cells.

432. Identification and expression analysis of ABC protein-encoding genes in Toxoplasma gondii. Toxoplasma gondii ATP-binding cassette superfamily.

433. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.

434. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.

435. Evaluation of a strategy for Toxoplasma gondii oocyst detection in water.

436. AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response.

438. P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii.

439. Factors influencing immune response after in vivo retrovirus-mediated gene transfer to the liver.

440. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles.

441. Use of co-immunoelectrodiffusion to detect presumed disease-associated precipitating antibodies, and time-course value of specific isotypes in bird-breeder's disease.

442. In-vivo retroviral gene transfer to the liver is cancelled by an immune response against the corrected cells. Can it be avoided?

443. lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

444. Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-alpha receptors on human cells in vitro.

445. Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat.

446. Involvement of secretory and cytosolic phospholipases A2 during infection of THP1 human monocytic cells with Toxoplasma gondii. Effect of interferon gamma.

447. In vivo cell lineage analysis in cyproterone acetate-treated rat liver using genetic labeling of hepatocytes.

Catalog

Books, media, physical & digital resources